PMID- 24198516 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20140624 LR - 20211021 IS - 1178-6957 (Print) IS - 1178-6957 (Electronic) IS - 1178-6957 (Linking) VI - 3 DP - 2010 Aug 26 TI - Hematopoietic stem cell transplantation. PG - 105-17 LID - 10.2147/SCCAA.S6815 [doi] AB - More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-deficiency illnesses, congenital metabolic defects, hemoglobinopathies, and myelodysplastic and myeloproliferative syndromes. Before transplantation, patients receive intensive myeloablative chemoradiotherapy followed by stem cell "rescue." Autologous HSCT is performed using the patient's own hematopoietic stem cells, which are harvested before transplantation and reinfused after myeloablation. Allogeneic HSCT uses human leukocyte antigen (HLA)-matched stem cells derived from a donor. Survival after allogeneic transplantation depends on donor-recipient matching, the graft-versus-host response, and the development of a graft versus leukemia effect. This article reviews the biology of stem cells, clinical efficacy of HSCT, transplantation procedures, and potential complications. FAU - Hatzimichael, Eleftheria AU - Hatzimichael E AD - Department of Haematology, Medical School of Ioannina, University of Ioannina, Ioannina, Greece. FAU - Tuthill, Mark AU - Tuthill M LA - eng PT - Journal Article PT - Review DEP - 20100826 PL - New Zealand TA - Stem Cells Cloning JT - Stem cells and cloning : advances and applications JID - 101535817 PMC - PMC3781735 OTO - NOTNLM OT - complications OT - hematopoietic stem cell transplantation EDAT- 2010/01/01 00:00 MHDA- 2010/01/01 00:01 PMCR- 2010/08/26 CRDT- 2013/11/08 06:00 PHST- 2013/11/08 06:00 [entrez] PHST- 2010/01/01 00:00 [pubmed] PHST- 2010/01/01 00:01 [medline] PHST- 2010/08/26 00:00 [pmc-release] AID - sccaa-3-105 [pii] AID - 10.2147/SCCAA.S6815 [doi] PST - epublish SO - Stem Cells Cloning. 2010 Aug 26;3:105-17. doi: 10.2147/SCCAA.S6815.